Updated safety phase I trial of anti-LAG-3 alone and in combination with anti-PD-1 in patients with recurrent GBM. Lim, M., Ye, X., Piotrowski, A. F., Desai, A., Ahluwalia, M., Walbert, T., Fisher, J. D., Desideri, S., Nabors, L. B., Wen, P. Y., Grossman, S. A. AMER SOC CLINICAL ONCOLOGY. 2020

View details for Web of Science ID 000560368301207